These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23473924)

  • 1. How to overcome surfactant dysfunction in meconium aspiration syndrome?
    Mokra D; Calkovska A
    Respir Physiol Neurobiol; 2013 Jun; 187(1):58-63. PubMed ID: 23473924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CC10 reduces inflammation in meconium aspiration syndrome in newborn piglets.
    Angert RM; Pilon AL; Chester D; Davis JM
    Pediatr Res; 2007 Dec; 62(6):684-8. PubMed ID: 17957145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant phosphatidylcholine metabolism in neonates with meconium aspiration syndrome.
    Janssen DJ; Carnielli VP; Cogo P; Bohlin K; Hamvas A; Luijendijk IH; Bunt JE; Tibboel D; Zimmermann LJ
    J Pediatr; 2006 Nov; 149(5):634-9. PubMed ID: 17095334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant therapy for meconium aspiration syndrome: current status.
    Dargaville PA; Mills JF
    Drugs; 2005; 65(18):2569-91. PubMed ID: 16392874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory treatment in dysfunction of pulmonary surfactant in meconium-induced acute lung injury.
    Mokra D; Drgova A; Kopincova J; Pullmann R; Calkovska A
    Adv Exp Med Biol; 2013; 756():189-96. PubMed ID: 22836635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiinflammatory Effect of N-Acetylcysteine Combined with Exogenous Surfactant in Meconium-Induced Lung Injury.
    Mikolka P; Kopincova J; Mikusiakova LT; Kosutova P; Calkovska A; Mokra D
    Adv Exp Med Biol; 2016; 934():63-75. PubMed ID: 27283193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant Injury in the Early Phase of Severe Meconium Aspiration Syndrome.
    Autilio C; Echaide M; Shankar-Aguilera S; Bragado R; Amidani D; Salomone F; Pérez-Gil J; De Luca D
    Am J Respir Cell Mol Biol; 2020 Sep; 63(3):327-337. PubMed ID: 32348683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Natural versus Synthetic Surfactant with SP-B and SP-C Analogs in a Porcine Model of Meconium Aspiration Syndrome.
    Salvesen B; Curstedt T; Mollnes TE; Saugstad OD
    Neonatology; 2014; 105(2):128-35. PubMed ID: 24356240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant replacement therapy for meconium aspiration syndrome.
    Findlay RD; Taeusch HW; Walther FJ
    Pediatrics; 1996 Jan; 97(1):48-52. PubMed ID: 8545223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory treatment of meconium aspiration syndrome: benefits and risks.
    Mokra D; Mokry J; Tonhajzerova I
    Respir Physiol Neurobiol; 2013 Jun; 187(1):52-7. PubMed ID: 23466955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IL-8 antibody potentiates the effect of exogenous surfactant in respiratory failure caused by meconium aspiration.
    Mikolka P; Kopincova J; Kosutova P; Kolomaznik M; Calkovska A; Mokra D
    Exp Lung Res; 2018 Feb; 44(1):40-50. PubMed ID: 29324051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant lavage in a piglet model of meconium aspiration syndrome.
    Paranka MS; Walsh WF; Stancombe BB
    Pediatr Res; 1992 Jun; 31(6):625-8. PubMed ID: 1635826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a recombinant surfactant protein-C-based surfactant on lung function and the pulmonary surfactant system in a model of meconium aspiration syndrome.
    Hilgendorff A; Doerner M; Rawer D; Leick J; Trotter A; Ebsen M; Ruppert C; Günther A; Gortner L; Reiss I
    Crit Care Med; 2006 Jan; 34(1):203-10. PubMed ID: 16374175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of surfactant/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury.
    Mikolka P; Kopincova J; Tomcikova Mikusiakova L; Kosutova P; Antosova M; Calkovska A; Mokra D
    J Physiol Pharmacol; 2016 Feb; 67(1):57-65. PubMed ID: 27010895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
    Wirbelauer J; Speer CP
    J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budesonide added to modified porcine surfactant Curosurf may additionally improve the lung functions in meconium aspiration syndrome.
    Mikolka P; Mokrá D; Kopincová J; Tomčíková-Mikušiaková L; Calkovská A
    Physiol Res; 2013; 62(Suppl 1):S191-200. PubMed ID: 24329699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of surfactant replacement on irregular overdistension of meconium-injured lungs in rats.
    Kobayashi T; Wu H; Cui X; Li W; Matsuhisa D; Tanaki N; Tashiro K
    Neonatology; 2008; 93(2):117-24. PubMed ID: 17709946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant metabolism in the neonate.
    Zimmermann LJ; Janssen DJ; Tibboel D; Hamvas A; Carnielli VP
    Biol Neonate; 2005; 87(4):296-307. PubMed ID: 15985752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant lavage decreases systemic interleukin-1 beta production in meconium aspiration syndrome.
    Wang PW; Jeng MJ; Wang LS; Fang LJ; Soong WJ
    Pediatr Int; 2010 Jun; 52(3):432-7. PubMed ID: 19919635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current strategy for management of meconium aspiration syndrome.
    Ogawa Y; Shimizu H
    Acta Paediatr Taiwan; 2000; 41(5):241-5. PubMed ID: 11100520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.